Chronic Lymphocytic Leukemia
Showing NaN - NaN of 30
Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax
Recruiting
- Chronic Lymphocytic Leukemia
-
London, London, City Of, United Kingdom
- +9 more
Jan 13, 2023
Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Kraków, Poland
- +10 more
Dec 2, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Boston, Massachusetts
- +11 more
Nov 23, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Obinutuzumab
- +3 more
-
Birmingham, Alabama
- +484 more
Aug 24, 2022
Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia
Active, not recruiting
- Relapsed/Refractory B Cell Malignancies
- +3 more
-
Columbus, Ohio
- +17 more
Aug 18, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Obinutuzumab
- +3 more
-
Huntsville, Alabama
- +153 more
Aug 19, 2022
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
-
Goshen, Indiana
- +44 more
Aug 3, 2022
Economic Analysis of Alliance A041202 CLL Study
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Calgary, Alberta, Canada
- +14 more
Jun 13, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib (ACP-196)
- +3 more
-
Chandler, Arizona
- +156 more
Jun 2, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- ABT-199 (Main Cohort)
- ABT-199 (Safety Expansion Cohort)
-
Tucson, Arizona
- +47 more
Nov 19, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Post-Chlorambucil Therapy Follow-up
- +4 more
-
Duarte, California
- +106 more
Aug 6, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021
Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Small-Cell Lymphoma
- Ibrutinib
- +2 more
-
La Jolla, California
- +70 more
Aug 27, 2020
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Bendamustine HCl, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ibrutinib
- +3 more
-
Birmingham, Alabama
- +159 more
Feb 20, 2020
Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic Trial in Worldwide (lenalidomide)
Completed
- Chronic Lymphocytic Leukemia
- Leukemia, B-Cell, Chronic
-
Tucson, Arizona
- +34 more
Nov 6, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)
Terminated
- Chronic Lymphocytic Leukemia
-
Huntsville, Alabama
- +44 more
Aug 12, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)
Terminated
- Chronic Lymphocytic Leukemia
-
Duarte, California
- +79 more
Aug 5, 2019
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Bendamustine, Rituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Idelalisib
- +3 more
-
Fullerton, California
- +90 more
Oct 19, 2018
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Duarte, California
- +107 more
Nov 27, 2017
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia Trial in United Kingdom, United States (BMN 673)
Completed
- Acute Myeloid Leukemia
- +3 more
- BMN 673
-
Indianapolis, Indiana
- +6 more
Sep 14, 2017
